Detalhe da pesquisa
1.
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Cancer
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662502
2.
Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients.
Int J Cancer
; 153(9): 1623-1634, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539667
3.
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 28(10): 917-e966, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339254
4.
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Cancer Control
; 30: 10732748231185047, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339926
5.
N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Oncologist
; 27(7): 534-e546, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35285484
6.
Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).
Pharmacogenet Genomics
; 31(9): 215-220, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34149004
7.
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 25(5): 380-e763, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31826977
8.
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer.
Clin Gastroenterol Hepatol
; 18(12): 2717-2723.e3, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811950
9.
Clinical impact of celiac ganglia metastasis upon pancreatic ductal adenocarcinoma.
Pancreatology
; 20(1): 110-115, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31759906
10.
Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).
Int J Cancer
; 145(2): 380-389, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623420
11.
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
Oncologist
; 24(5): 589-e160, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679315
12.
Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone.
Clin Gastroenterol Hepatol
; 17(4): 728-738.e9, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217513
13.
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.
J Natl Compr Canc Netw
; 17(4): 302-310, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959462
14.
Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma.
HPB (Oxford)
; 21(3): 379-386, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266490
15.
EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer.
Gastrointest Endosc
; 86(1): 161-169, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889543
16.
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.
J Natl Compr Canc Netw
; 15(5): 563-573, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476736
17.
Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.
Int J Cancer
; 139(5): 986-95, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060850
18.
Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).
Pharmacogenet Genomics
; 26(3): 133-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26658227
19.
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Oncologist
; 21(12): 1509-1521, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881709
20.
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Gastroenterology
; 148(1): 88-99, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25305506